The chemical class termed LOC100040870 Inhibitors encompasses a specialized group of compounds designed to target and inhibit the activity of the gene product associated with LOC100040870. This gene, identified through sophisticated genomic studies, has been recognized for its involvement in a variety of cellular functions and mechanisms. The role of LOC100040870 in cellular processes is characterized by its context-dependency, with its function varying in response to different cellular environments and external factors. The inhibitors targeting LOC100040870 are precisely developed to bind selectively to the proteins or enzymes that are produced as a result of the gene's expression. This selective binding is a critical feature of these inhibitors, as it allows them to directly influence the biochemical pathways involving the LOC100040870 gene product. By modulating the activity of this gene product, the inhibitors are intended to impact the associated cellular processes, thus playing a significant role in altering certain cellular functions and activities.
The development of LOC100040870 Inhibitors is a complex and interdisciplinary task, incorporating insights from molecular biology, chemistry, and structural biology. The process begins with an in-depth understanding of the structure and function of the LOC100040870 gene product. Techniques like X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and computational molecular modeling are extensively utilized to gain detailed insights into the target molecule. This foundational knowledge is essential for the rational design of inhibitors that are both effective in their interaction with the target and exhibit high selectivity. Typically, these inhibitors are small molecules, designed to efficiently penetrate cellular membranes and engage in stable and potent interactions with their target. The molecular design of these inhibitors is meticulously optimized to ensure robust interactions with the target molecule, often involving the formation of hydrogen bonds, hydrophobic interactions, and van der Waals forces. The effectiveness of these inhibitors is evaluated through various biochemical assays in vitro. These assays are crucial in assessing the potency, specificity, and overall behavior of the inhibitors under controlled experimental conditions. Such research is vital for understanding the inhibitors' mechanism of action and for further exploration into their interaction dynamics and potential influence on cellular pathways and functions.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin intercalates into DNA, potentially hindering transcriptional processes and inhibiting gene expression. | ||||||
Aphidicolin | 38966-21-1 | sc-201535 sc-201535A sc-201535B | 1 mg 5 mg 25 mg | $84.00 $306.00 $1104.00 | 30 | |
Aphidicolin specifically inhibits DNA polymerase α and δ, potentially reducing DNA replication and gene expression. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin forms DNA adducts and crosslinks, potentially disrupting transcription and inhibiting gene expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine incorporates into RNA and DNA, potentially affecting methylation patterns and inhibiting gene expression. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts protein trafficking by inhibiting the Golgi apparatus, potentially affecting protein expression. | ||||||
Leflunomide | 75706-12-6 | sc-202209 sc-202209A | 10 mg 50 mg | $20.00 $83.00 | 5 | |
Leflunomide inhibits dihydroorotate dehydrogenase, potentially affecting pyrimidine synthesis and reducing gene expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Decitabine is incorporated into DNA and inhibits DNA methyltransferase, potentially affecting gene expression patterns. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A inhibits histone deacetylases, potentially altering chromatin structure and inhibiting gene expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate acts as a histone deacetylase inhibitor, potentially affecting chromatin accessibility and gene expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, potentially affecting various signaling pathways and gene expression. | ||||||